Peptide Lead Optimization
Peptide Lead Optimization is a drug discovery process that involves the systematic modification and refinement of initial peptide hits to enhance their pharmacological properties, such as potency, selectivity, metabolic stability, and bioavailability, while maintaining target specificity, within the context of developing viable therapeutic candidates.
47
Publications
2.8K
Citations
365
Authors
98
Institutions
Publications per year
2017–2026
13
Parents
47
Yong S. Chang, Bradford Graves, Vincent Guerlavais et al. · Proceedings of the National Academy of Sciences · 2013 · 661 citations · Full text
Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide
Jan Münch, Ludger Ständker, Knut Adermann et al. · Cell · 2007 · 268 citations · Full text
1–5 of 47
365
Yunusov Institute of the Chemistry of Plant Substances, Uzbekistan
3 publications · 82 citations
3
h-index
3
h-index
3
h-index
3
h-index
2
h-index
1–5 of 365
98
Korea Food Research Institute
Wanju, South Korea
3 h-index
8 publications
196 citations
Yunusov Institute of the Chemistry of Plant Substances
Tashkent, Uzbekistan
3 h-index
6 publications
162 citations
University of Ferrara
Ferrara, Italy
2 h-index
5 publications
89 citations
University of Arizona
Tucson, United States
2 h-index
19 publications
1.1K citations

Seikei University
Musashino, Japan
2 h-index
3 publications
40 citations
Vanderbilt University Medical Center
Nashville, United States
2 h-index
13 publications
787 citations

University of Modena and Reggio Emilia
Modena, Italy
2 h-index
22 publications
376 citations
Tokyo Medical and Dental University
Tokyo, Japan
2 h-index
5 publications
60 citations
1–8 of 98
8 publications · 377 citations
8
h-index
6 publications · 195 citations
6
h-index
3 publications · 47 citations
3
h-index
2 publications · 68 citations
2
h-index
JBC · 2 publications · 124 citations
2
h-index
1–5